These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 34913949)
1. Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer. Song M; Camargo MC; Katki HA; Weinstein SJ; Männistö S; Albanes D; Surcel HM; Rabkin CS JAMA Oncol; 2022 Feb; 8(2):268-274. PubMed ID: 34913949 [TBL] [Abstract][Full Text] [Related]
2. Serologic Profile of Antiparietal Cell Antibodies, Pepsinogens, and Wang SM; Roth MJ; Murphy GA; Dawsey SM; Fan JH; Taylor PR; Qiao YL; Abnet CC Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2022-2029. PubMed ID: 31501152 [TBL] [Abstract][Full Text] [Related]
3. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193 [TBL] [Abstract][Full Text] [Related]
4. No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese. Hishida A; Matsuo K; Goto Y; Mitsuda Y; Hiraki A; Naito M; Wakai K; Tajima K; Hamajima N Gastric Cancer; 2010 Mar; 13(1):43-9. PubMed ID: 20373075 [TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study. Huang J; Zagai U; Hallmans G; Nyrén O; Engstrand L; Stolzenberg-Solomon R; Duell EJ; Overvad K; Katzke VA; Kaaks R; Jenab M; Park JY; Murillo R; Trichopoulou A; Lagiou P; Bamia C; Bradbury KE; Riboli E; Aune D; Tsilidis KK; Capellá G; Agudo A; Krogh V; Palli D; Panico S; Weiderpass E; Tjønneland A; Olsen A; Martínez B; Redondo-Sanchez D; Chirlaque MD; Hm Peeters P; Regnér S; Lindkvist B; Naccarati A; Ardanaz E; Larrañaga N; Boutron-Ruault MC; Rebours V; Barré A; Bueno-de-Mesquita HB; Ye W Int J Cancer; 2017 Apr; 140(8):1727-1735. PubMed ID: 28032715 [TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric Cancer. Xu HM; Han Y; Liu ZC; Yin ZY; Wang MY; Yu C; Ma JL; Sun D; Liu WD; Zhang Y; Zhou T; Zhang JY; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Chen Z; You WC; Li L; Pan KF; Lv J; Li WQ JAMA Netw Open; 2024 May; 7(5):e2413708. PubMed ID: 38809553 [TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort. Yuan JM; Yu MC; Xu WW; Cockburn M; Gao YT; Ross RK Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):621-4. PubMed ID: 10428200 [TBL] [Abstract][Full Text] [Related]
8. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Lin JT; Wang LY; Wang JT; Wang TH; Yang CS; Chen CJ Anticancer Res; 1995; 15(2):603-6. PubMed ID: 7763044 [TBL] [Abstract][Full Text] [Related]
9. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Aromaa A; Kosunen TU; Knekt P; Maatela J; Teppo L; Heinonen OP; Härkönen M; Hakama MK Am J Epidemiol; 1996 Jul; 144(2):142-9. PubMed ID: 8678045 [TBL] [Abstract][Full Text] [Related]
10. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Epplein M; Zheng W; Xiang YB; Peek RM; Li H; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Shu XO Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2185-92. PubMed ID: 23035179 [TBL] [Abstract][Full Text] [Related]
12. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study. Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S; Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334 [TBL] [Abstract][Full Text] [Related]
13. Seropositivity to Helicobacter pylori and risk of pancreatic cancer. Yu G; Murphy G; Michel A; Weinstein SJ; Männistö S; Albanes D; Pawlita M; Stolzenberg-Solomon RZ Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2416-9. PubMed ID: 24089457 [TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. Lee AA; Wang QL; Kim J; Babic A; Zhang X; Perez K; Ng K; Nowak J; Rifai N; Sesso HD; Buring JE; Anderson GL; Wactawski-Wende J; Wallace R; Manson JE; Giovannucci EL; Stampfer MJ; Kraft P; Fuchs CS; Yuan C; Wolpin BM Clin Transl Gastroenterol; 2023 May; 14(5):e00573. PubMed ID: 36854058 [TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors. Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354 [TBL] [Abstract][Full Text] [Related]
16. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males. Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850 [TBL] [Abstract][Full Text] [Related]
17. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: evaluation in a country of high prevalence of atrophic gastritis. Ito M; Haruma K; Kaya S; Kamada T; Kim S; Sasaki A; Sumii M; Tanaka S; Yoshihara M; Chayama K Scand J Gastroenterol; 2002 Mar; 37(3):287-93. PubMed ID: 11916190 [TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study. Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185 [TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan. Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299 [TBL] [Abstract][Full Text] [Related]
20. Song L; Song M; Rabkin CS; Williams S; Chung Y; Van Duine J; Liao LM; Karthikeyan K; Gao W; Park JG; Tang Y; Lissowska J; Qiu J; LaBaer J; Camargo MC J Proteome Res; 2021 Jan; 20(1):409-419. PubMed ID: 33108201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]